Literature DB >> 12196514

Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity.

Petra Schling1, Thorsten Schäfer.   

Abstract

Human adipose tissue expresses all components necessary for the local production of angiotensin II, which has multiple functions in adipose tissue, ranging from regulation of local blood flow to complex influences on tissue homeostasis. Still the mechanisms controlling human adipose tissue angiotensin II concentrations are not yet known. We investigated whether angiotensin II is degraded by human primary cultured preadipocytes and adipocytes and which enzymes are responsible for its metabolism. Distinct but transient angiotensin II production was limited by degradation due to consecutive proteolytic cleavage by endopeptidase and aminopeptidase activities. The endopeptidase could be identified as neprilysin expressed on the surface of both preadipocytes and adipocytes. Degradation of angiotensin II was preceded by a lag phase that was considerably longer in preadipocytes. This time span could not be explained by an induction of neprilysin nor by an increase in its surface localization. Following the lag phase, adipocytes showed a higher degradation activity than preadipocytes as mirrored by increased neprilysin levels and activity measured in their membrane fractions. Our findings demonstrate that human preadipocytes and adipocytes differentially express functional neprilysin and aminopeptidase activity involved in the regulation of angiotensin II concentrations in human adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196514     DOI: 10.1074/jbc.M204058200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Effect of treatment of high fat fed/low dose streptozotocin-diabetic rats with Ilepatril on vascular and neural complications.

Authors:  Eric P Davidson; Lawrence J Coppey; Amey Holmes; Brian Dake; Mark A Yorek
Journal:  Eur J Pharmacol       Date:  2011-07-28       Impact factor: 4.432

2.  Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats.

Authors:  Christine L Oltman; Eric P Davidson; Lawrence J Coppey; Travis L Kleinschmidt; Brian Dake; Mark A Yorek
Journal:  Eur J Pharmacol       Date:  2010-10-30       Impact factor: 4.432

3.  Metabolic effects of sacubitril/valsartan: are they relevant in clinical practice?

Authors:  Rafael de la Espriella-Juan; Juan Sanchis; Antoni Bayés-Genís; Julio Núñez
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

4.  RIP140-targeted repression of gene expression in adipocytes.

Authors:  Mark Christian; Evangelos Kiskinis; Darja Debevec; Göran Leonardsson; Roger White; Malcolm G Parker
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

5.  Neprilysin facilitates adipogenesis through potentiation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway.

Authors:  Juwan Kim; Dasol Han; Sung-Hyun Byun; Mookwang Kwon; Sun-Jung Cho; Young Ho Koh; Keejung Yoon
Journal:  Mol Cell Biochem       Date:  2017-02-27       Impact factor: 3.396

6.  Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice.

Authors:  Frederique Yiannikouris; Manisha Gupte; Kelly Putnam; Sean Thatcher; Richard Charnigo; Debra L Rateri; Alan Daugherty; Lisa A Cassis
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

Review 7.  The adipose renin-angiotensin system: role in cardiovascular disease.

Authors:  Sean Thatcher; Frederique Yiannikouris; Manisha Gupte; Lisa Cassis
Journal:  Mol Cell Endocrinol       Date:  2009-04-29       Impact factor: 4.102

8.  Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension.

Authors:  Yasir AlSiraj; Sean E Thatcher; Ching Ling Liang; Heba Ali; Mark Ensor; Lisa A Cassis
Journal:  J Pharmacol Exp Ther       Date:  2021-03-11       Impact factor: 4.030

9.  Neprilysin, obesity and the metabolic syndrome.

Authors:  K F Standeven; K Hess; A M Carter; G I Rice; P A Cordell; A J Balmforth; B Lu; D J Scott; A J Turner; N M Hooper; P J Grant
Journal:  Int J Obes (Lond)       Date:  2010-11-02       Impact factor: 5.095

10.  Angiotensin II signaling in human preadipose cells: participation of ERK1,2-dependent modulation of Akt.

Authors:  Natalia Dünner; Carolina Quezada; F Andrés Berndt; José Cánovas; Cecilia V Rojas
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.